Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer

NCT00033735 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: fluorouracil
DRUG: Irofulven

Sponsor

Eisai Inc.